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ABSTRACT
Background: A comparative study is made of the anesthetic efficacy of 4% articaine versus 2% lidocaine, both with 
epinephrine 1:100,000, in truncal block of the inferior alveolar nerve during the surgical extraction of impacted lower 
third molars.
Study design: A randomized double-blind clinical trial was conducted of 30 patients programmed for the bilateral 
surgical extraction of symmetrical lower third molars in the context of the Master of Oral Surgery and Implantology 
(University of Barcelona, Barcelona, Spain). Following the obtainment of informed consent, two operators performed 
surgery on an extemporaneous basis, using as local anesthetic 4% articaine or 2% lidocaine with the same concentration 
of vasoconstrictor (epinephrine 1:100,000). The study variables for each anesthetic were: latency (time to action) and 
duration of anesthetic effect, the amount of anesthetic solution used, and the need of re-anesthetize the surgical zone. 
A visual analog scale was used to assess pain during surgery, and thus subjectively evaluate the anesthetic efficacy of 
the two solutions.
Results: Statistically significant differences (p = 0.003) were observed in the mean duration of anesthetic effect (220.86 
min. for 4% articaine vs. 168.20 min. for 2% lidocaine). Latency, the amount of anesthetic solution and the need to 
re-anesthetize the surgical field showed clinical differences in favor of articaine, though statistical significance was not 
reached. The pain scores indicated similar anesthetic efficacy with both solutions.
Conclusions: The results obtained suggest that 4% articaine offers better clinical performance than 2% lidocaine, par-
ticularly in terms of latency and duration of the anesthetic effect. However, no statistically significant differences in 
anesthetic efficacy were recorded between the two solutions.
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INTRODUCTION
Pain control through truncal block of the inferior alveolar 
nerve is one of the locoregional anesthetic techniques most 
widely used in oral surgery, affording comfort and safety 
for both the patient and operator when used correctly. The 
choice of anesthetic solution should be based on three main 
clinical considerations: anesthetic potency, latency (time to 
onset of anesthesia), and duration of the anesthetic effect 
(1). Other important considerations are the pharmacokine-
tics (absorption, distribution, metabolization and excretion) 
and toxicity of the drug. Lidocaine, synthesized by Löfgren 
in 1943, was the first amide anesthetic prepared for local 
application, and the only marketed representative of this 
drug group with topical action. Its potency is presently 
regarded as the standard for comparison with other local 
anesthetics (2). The latency of lidocaine varies from 2-3 mi-
nutes, with an approximate duration of anesthetic effect for 
2% solutions with epinephrine 1:100,000 as vasoconstrictor 
of 85 minutes at pulp level, and 190 minutes in soft tissues 
(3). Lidocaine is the local anesthetic most widely used for 
pain control, since its pharmacokinetic characteristics and 
low toxicity compared with other ester-type anesthetics 
make it safe for use in dental practice (1,2,4,5).
Articaine hydrochloride (HCl), or 4-methyl-3-[1-oxo-2-
(propylamino)-propionamido]-2-thiophene-carboxylic acid 
methyl ester hydrochloride, was synthesized by Rusching et 
al. in 1969 with the name of carticaine, and was first mar-
keted in Germany in 1976. By 1983 the drug was available 
in practically all of Europe and Canada, though it was not 
approved in the United States until March 2000, and only in 
its presentation as a 4% solution with epinephrine 1:100,000 
(6). The pharmacological characteristics of this anesthetic 
are responsible for its main advantages with respect to other 
local anesthetics, and include substitution of the aromatic 
ring with a thiophenic ring that increases the liposolubility 
of the drug as well as its potency (1.5 times greater than 
that of lidocaine). Moreover, articaine is the only amide 
local anesthetic containing an ester group in its molecular 
structure – thus allowing metabolization of the drug both 
by plasma esterases and by liver microsomal enzymes (7).
The clinical advantages of articaine include the duration of 
its anesthetic effect – only surpassed by ultra-long acting 
anesthetics such as bupivacaine, ethidocaine and ropivacaine 
– and its superior diffusion through bony tissue (8,9). Lemay 
et al. (10) found the mean latency of articaine to be 2.01 
minutes. In comparison, Martínez et al. (11) recorded 2.9 
minutes, while other authors such as Berini and Gay-Escoda 
(1) and Malamed (2) reported times to anesthesia onset of 
1-2 minutes. The duration of the anesthetic effect varies 
according to the amount of vasoconstrictor added to the 
commercial formulation. Thus, in Europe 4% articaine with 
epinephrine 1:100,000 is usually used, yielding approximate 
durations of anesthesia of 75 and 240 minutes at pulp and 
soft tissue level, respectively. Another common presentation 
is 4% articaine with epinephrine 1:200,000, yielding anesthe-
tic durations of 45 and 180 minutes at pulp and soft tissue 
level, respectively (5,12).
Since the introduction of articaine on the market, a number 
of studies have evaluated its advantages with respect to other 
local anesthetics. In this sense, many authors have been 
RESUMEN
Objetivo: Valorar y comparar la eficacia anestésica de la Articaína al 4% respecto a la Lidocaína al 2%, ambas con 
una concentración de 1:100.000 de epinefrina en el bloqueo  troncal del nervio alveolar inferior durante la extracción 
quirúrgica de terceros molares inferiores incluidos.
Diseño del estudio: Se realizó un ensayo clínico aleatorio a doble ciego en una muestra de 30 pacientes programados para 
las extracciones quirúrgicas bilaterales de terceros molares inferiores simétricos en el Servicio de Cirugía Bucal del Máster 
de Cirugía e Implantología Bucal de la Universidad de Barcelona. Previo consentimiento del paciente, dos operadores 
efectuaron las intervenciones quirúrgicas de forma extemporánea, utilizando como anestésico local la Articaína al 4% o 
la Lidocaína al 2 % con la misma concentración de vasoconstrictor (epinefrina 1:100.000). Las variables estudiadas para 
cada anestésico fueron: tiempo de latencia (o de inicio del efecto anestésico), duración del efecto anestésico, cantidad 
de solución anestésica utilizada y la necesidad de reanestesiar la zona operatoria. Se utilizó una escala analógica visual 
para valorar la cantidad de dolor experimentado durante el acto quirúrgico y, así, evaluar subjetivamente la profundidad 
anestésica de las dos soluciones.
Resultados: Se observaron diferencias estadísticamente significativas (p= .003) en cuanto a la duración del efecto anes-
tésico, que fue mayor para la artcaína al 4% (220,8 minutos), respecto a la lidocaína al 2% (168,20 minutos). En las 
variables tiempo de latencia, cantidad de solución anestésica utilizada y necesidad de reanestesiar el campo operatorio 
se evidenciaron diferencias clínicas a favor de la articaína, aunque estas diferencias no fueron estadísticamente signi-
ficativas. La valoración cualitativa de los anestésicos mediante la escala analógica visual mostró similitud en el dolor 
experimentado por los pacientes con ambos anestésicos. 
Conclusiones: De acuerdo con los resultados obtenidos se puede afirmar que la articaína al 4% muestra mejores carac-
terísticas clínicas que la lidocaína al 2%, especialmente en cuanto al tiempo de latencia y duración del efecto anestésico. 
Sin embargo, no hubieron diferencias estadísticamente significativas que confirmen la superioridad de una solución 
respecto a la otra, al valorar la eficacia anestésica. 
Palabras clave: Articaína, Lidocaína, eficacia anestésica, tercer molar inferior incluido.
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unable to demonstrate superior anesthetic efficacy versus 
other agents such as 4% prilocaine (13) or 2% lidocaine 
with epinephrine 1:80,000 (14). Nevertheless, Malamed et 
al. (7,15), after comparing the drug with 2% lidocaine and 
epinephrine 1:100,000, reported articaine to be a safe local 
anesthetic that can be used in both adults and children, 
with an anesthetic latency and duration that makes it ade-
quate for clinical use and comparable to the rest of local 
anesthetics (7, 15).
The present study compares the anesthetic efficacy of 
4% articaine versus 2% lidocaine, both with epinephrine 
1:100,000, in application to truncal block of the inferior 
alveolar nerve during the surgical extraction of impacted 
lower third molars.
MATERIAL AND METHODS
Two operators enrolled in the second and third course of 
the Master of Oral Surgery and Implantology (Service of 
Oral and Maxillofacial Surgery, University of Barcelona 
Dental School, Spain) conducted a randomized double-
blind clinical trial of 30 patients (13 males and 17 females; 
mean age 23.72 years (standard deviation (SD): 0.71), range 
18-36 years) programmed for bilateral surgical extraction of 
the lower third molars. The inclusion criteria were: subjects 
over age 18, without systemic disorders or antecedents of 
complications associated with local anesthetics, and pre-
senting impacted symmetrical lower third molars requiring 
ostectomy and tooth sectioning for extraction. The exclusion 
criteria were: the existence of acute infection and/or swelling 
at the time of surgery, and interventions in which anesthe-
tic latency exceeded 5 minutes. Operations lasting more 
than 60 minutes were also excluded, as were those patients 
presenting intra- or postoperative complications such as 
paresthesia or dysesthesia of the inferior alveolar nerve.
After obtaining informed consent, surgery was performed 
on an extemporaneous basis, with a minimum washout 
period of one month between operations, and using 4% 
articaine (Articaine 4% Inibsa®, Inibsa, Barcelona, Spain) 
or 2% lidocaine (Xylonibsa®, Inibsa, Barcelona, Spain) 
as anesthetic solution, with the same concentration of 
vasoconstrictor (epinephrine 1:100,000) in both cases. The 
patients were randomly assigned to one of the two anes-
thetic groups.
Direct truncal block of  the inferior alveolar nerve was 
performed, complemented with vestibular and retromolar 
trigone infiltration for anesthetic block of the buccal nerve, 
using a 25G needle 35 mm in length (Nissho Nipro, Zaven-
tem, Belgium) for truncal block, and a 27G needle 25 mm 
in length (Nissho Nipro, Zaventem, Belgium) for infiltration 
block. A 1.8-ml cartridge of anesthetic solution was injected 
in 60 seconds for inferior alveolar nerve block, while another 
1.8-ml cartridge was used for buccal nerve anesthesia. The 
anesthetic techniques were performed on a random basis 
by one of the two operators. Each operator performed the 
two extractions in the same patient - each with one type 
of anesthesia. After injection of the anesthetic solution, 
the time to anesthetic effect was recorded (defined as the 
time elapsed from full needle withdrawal until the patient 
referred the first evidence of Vincent’s sign). The duration 
of anesthesia was in turn recorded as the time from initial 
patient perception of the anesthetic effect to the moment 
in which the effect began to fade.
Evaluation was also made of  the need to re-anesthetize 
the surgical zone, specifying the technique and amount of 
anesthetic injected. The anesthetic techniques used to re-
anesthetize the surgical field comprised the intraligamentous 
and intrapulpal approaches – the latter only being used 
when anesthetic reinforcement proved necessary at the time 
of tooth sectioning. A visual analog scale (VAS) from 0 to 
100 millimeters was used to subjectively assess the depth 
of anesthesia – each patient scoring pain intensity during 
surgery and after the operation.
The statistical analysis of the results was carried out with 
the Student t- and chi-square tests, using the SPSS version 
11.0 statistical package throughout.
RESULTS
Of the 30 patients, three were excluded from the study: one 
due to the development of transient inferior alveolar nerve 
paresthesia, another because of transient paresthesia of the 
lingual nerve, and the third as a result of voluntary dropout 
from the study. A total of 54 interventions were included in 
the study: 24 performed with 2% lidocaine, and 30 with 4% 
articaine (with epinephrine 1:100,000 in both cases). In most 
cases extraction was decided for prophylactic reasons (33% 
of cases), followed by orthodontic indications (27.8%), a 
history of pericoronaritis (25.9%), anterior crowding (5.6%), 
pain alone (5.6%), and periodontal lesion of the lower se-
cond molar (1.9%). The mean duration of surgery was 22.57 
minutes (SD: 1.27), without significant differences between 
the two groups. The mean anesthetic latency for lidocaine 
was 75.04 seconds (SD: 14.8), versus 56.03 seconds (SD: 
9.76) for articaine – no statistically significant differences 
being observed between the two anesthetic solutions. In 
turn, the mean duration of the anesthetic effect was 220.86 
minutes (SD: 13.81) for articaine and 168.20 minutes (SD: 
10.77) for lidocaine – the difference in this case being sta-
tistically significant (p = 0.003)(Table 1).
In 16 interventions (29.6% of cases) re-anesthesia of the 
surgical zone proved necessary. The frequency of the techni-
ques used, differentiated by anesthetic solutions, is reflected 
in Table 2. The nonparametric chi-square test revealed no 
significant differences between the need for re-anesthesia 
with articaine or lidocaine (p = 0.128). However, in terms 
of the amount of anesthetic solution used (including the 
cases of re-anesthesia) during the operation to achieve the 
desired anesthetic effect, larger volumes of 2% lidocaine 
with epinephrine 1:100,000 were required, administering an 
average of 4.20 ml (SD = 0.19) per operation (equivalent to 
2.3 standard carpules), versus 3.86 ml (SD = 0.09) in the case 
of 4% articaine with epinephrine 1:100,000 (equivalent to 
2.1 standard carpules). This differences did not quite reach 
statistical significance, however (p = 0.052).
E142
Med Oral Patol Oral Cir Bucal 2007;12:E139-44.                                                                                                                           Comparative study of the anesthetic efficacy of 4% articaine versus 2% lidocaine                                                         Med Oral Patol Oral Cir Bucal 2007;12:E139-44.                                                                                                                       Comparative study of the anesthetic efficacy of 4% articaine versus 2% lidocaine 
Lastly, subjective intraoperative pain scoring by the patients 
showed no differences between the two anesthetic solutions, 
with mean VAS scores of 13.81 mm (SD: 3.012) and 12.83 mm 
(SD: 3.186) for articaine and lidocaine, respectively (Table 1). A 
value reported by one of the patients for articaine was excluded, 
since scoring proved erroneous because the patient failed to 
understand the pain-evaluating instructions provided.
DISCUSSION
The diversity of anesthetic substances currently available on 
the market requires dental professionals to assess both the 
pharmacokinetic and clinical characteristics of each drug 
solution, in adaptation to the needs of each individual 
dental intervention. Since its introduction in 1969, articaine 
has gradually become implanted in Europe. Its chemical 
structure, different to that of other local anesthetics due to 
substitution of the aromatic ring with a thiophenic ring, and 
the presence of an additional ester ring, provides articaine 
with increased liposolubility and intrinsic potency, as well as 
greater plasma protein binding versus other commonly used 
local anesthetic such as prilocaine or mepivacaine. These 
differential characteristics are in turn clinically reflected by 
a shorter latency and increased duration of anesthesia, as 
well as superior bony tissue diffusion (1,7,8,9).
The latency of an anesthetic depends on a number of factors, 
such as the intrinsic properties of the drug substance used, 
 N Mean SD Range 
L 24 22.0 1.85 12 - 50 Duration of surgery (min.) 
(p = 0.468) A 30 22.2 1.64 10 - 40 
L 24 75.0 14.02 17 - 300 Latency (sec.)  
(p = 0.137) A 30 56.0 09.43 10 - 250 
L 24 168.2 10.77 74 - 336 Duration of anesthesia (min.) 
(p = 0.003) A 30 220.8 13.81 57 - 416 
L 24 12.8 3.19 0 - 48 Intraoperative pain (mm) 




N % N % 
No re-anesthesia 15 62.5 23 76.7
Intraligamentous 8 33.3 4 13.3
Intrapulpal 1 4.2 3 10 
 Total 24 100 30 100 
Table 2. Frequency of re-anesthesia according to 
the local anesthetic solution used and the anesthe-
tic reinforcement technique involved.
Table 1. Duration of impacted third molar surgical extraction, anesthetic latency 
and duration, and intraoperative pain with 4% articaine and 2% lidocaine (both 
with epinephrine 1:100,000 as vasoconstrictor).
L: 2% lidocaine; A: 4% articaine (with epinephrine 1:100.000 as vasoconstrictor 
in all cases).
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and the anesthetic technique employed. On the other hand, 
latency is directly influenced by the corresponding pKa value 
- smaller pKa values being associated to shorter latency. Ac-
cordingly, 4% articaine (pKa = 7.8) would at least in theory 
present a shorter latency than 2% lidocaine (pKa = 7.9). Our 
results coincide with this assumption, since the latency was 
1.3 times shorter for articaine versus lidocaine. 
On the other hand, the recorded latencies for both anesthetic 
substances were shorter than reported by other authors. 
This may be because we measured latency from the mo-
ment of needle withdrawal from the patient soft tissues, 
while in contrast other investigators such as Cowan (16), 
in a comparative study of 4% carticaine (the early name 
used for articaine) and the rest of amide local anesthetics, 
recorded latency from the moment of needle insertion and 
injection of the anesthetic. This author found the latency 
of articaine in application to mandibular block to be 1.48 
minutes (16). According to other authors such as Malamed 
et al. (2), the latency of 4% articaine in mandibular block 
is 2-2.30 minutes, while Berini and Gay-Escoda (1) repor-
ted a latency of 2 minutes. In the case of lidocaine, both 
authors referred latencies in the range of 2-3 minutes. In 
our experience the latency of articaine was 56.03 seconds 
(0.93 minutes), versus 75.04 seconds (1.25 minutes) in the 
case of lidocaine. The difference between the two anesthetic 
solution was not significant.
The duration of the effect of an anesthetic is proportional 
to its degree of protein binding. However, the duration of 
the effect of the local anesthetic is also dependent on the 
injection site or concentration of vasoconstrictor present 
in the anesthetic solution, among other factors. Articaine 
presents one of the greatest protein binding percentages of 
all amide local anesthetics, comparable only to ultra-long 
action substances such as bupivacaine, ropivacaine and 
ethidocaine. This in turn implies a longer duration of the 
anesthetic effect (1). In our study, the duration of articaine 
anesthetic effect varied from 57-416 minutes (0.40-6.95 
hours, respectively). These values are comparable to those 
reported in the literature (1,9,10,15), and are significantly 
longer than in the case of lidocaine. Nevertheless, conside-
ring the mean duration of the surgical interventions in our 
study, the 166.04 minutes of soft tissue anesthesia afforded 
by lidocaine are more than enough for the surgical extraction 
of an impacted lower third molar.
In this study a clinical evaluation of the efficacy of  the 
two anesthetic solutions was made by comparing the need 
for re-anesthesia during dental surgery, in view of  the 
impossibility of performing an electric pulp stimulus test 
for the objective assessment of anesthetic efficacy. In 16 
interventions (29.62% of cases) another dose of anesthetic 
solution had to be administered via either the intrapulpal 
or intraligamentous technique. The number of repeat anes-
thetic procedures was greater when using 2% lidocaine. As a 
result, the total volume of anesthetic solution administered 
was 1.7 times greater than in the case of 4% articaine. On the 
other hand, this difference in the total amount of anesthetic 
solution used (0.31 ml) was similar to the value reported by 
Malamed et al. (7) in their multicenter study of 1325 adult 
patients. However, the difference in both the mean frequency 
and amount of solution used for re-anesthesia of the surgical 
zone failed to reach statistical significance.
Subjective evaluation of the local anesthetics used in the 
present study (including those cases where re-anesthesia 
proved necessary) was made by means of a visual analog 
scale (VAS) in which the patient was instructed to score 
intraoperative pain intensity. The mean scores for 2% lido-
caine and 4% articaine (both with epinephrine 1:100,000 
as vasoconstrictor) were not significantly different. These 
results are comparable to those obtained in other studies 
contrasting the performance of these two local anesthetics 
(14,15,17,18).
Articaine was the anesthetic used in the two patients ex-
cluded from the study due to the appearance of transient 
paresthesia of the inferior alveolar nerve and lingual nerve. 
Haas and Lemmon (19), in a review of 143 paresthesias, 
found the latter to be more frequent when articaine and 
prilocaine were used. On the other hand, Malamed et al. (7) 
also reported an increased incidence of nerve alterations, 
paresthesias and hyperesthesias, when administering 4% 
articaine with epinephrine 1:100,000 versus 2% lidocaine 
at the same vasoconstrictor concentration – suggesting a 
possible greater neurotoxic effect on the part of articaine. In 
this sense, Peñarrocha et al. (20) documented 14 cases of eye 
problems when using this anesthetic for infraorbital nerve 
block. Among the causes for these complications, the au-
thors mentioned the possibility of increased diffusion of this 
anesthetic within the soft tissues and bone – thus facilitating 
articaine penetration to the orbital cavity. In our experience, 
and despite the fact that the two cases presenting paresthesia 
were both anesthetized with articaine, there is insufficient 
evidence to believe the underlying cause to be the type of 
anesthetic used. We therefore consider that further studies 
are needed to establish such a possible relationship.
CONCLUSIONS
The results obtained suggest that 4% articaine offers better 
pharmacological performance than 2% lidocaine, particular-
ly in terms of latency and duration of the anesthetic effect. 
However, no statistically significant differences in anesthetic 
efficacy were recorded between the two solutions.
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